Compound Detail
CHEMBL558752
RAF-265 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21
Basic Information
| ChEMBL ID | CHEMBL558752 |
| Name | RAF-265 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | YABJJWZLRMPFSI-UHFFFAOYSA-N |
73
Targets
175
Activities
2
Assay Types
16
PK Parameters
20
Publications
5
Known Names
2
Indications
2
Mechanisms
Molecular Properties
518.4
MW (Da)
6.93
ALogP
6
HBA
2
HBD
80.7
PSA (Ų)
0.25
QED
2
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase B-raf inhibitor | INHIBITOR | Serine/threonine-protein kinase B-raf | ✓ | ✓ |
| Vascular endothelial growth factor receptor 2 inhibitor | INHIBITOR | Vascular endothelial growth factor receptor 2 | ✓ | ✓ |
Indications
Melanoma Neoplasms
Activity Summary
Kd 147 meas. best 7.89
IC50 28 meas. best 9.3
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 233289.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2229206.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 18144.7 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 24884.16 | ng.hr.mL-1 | Macaca mulatta |
| CL | 0.8 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 0.9 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.1 | mL.min-1.kg-1 | Mus musculus |
| CL | 1.5 | mL.min-1.kg-1 | Macaca mulatta |
| F | 35.0 | % | Canis lupus familiaris |
| F | 95.0 | % | Rattus norvegicus |
| F | 51.0 | % | Mus musculus |
| F | 48.0 | % | Macaca mulatta |
| T1/2 | 46.0 | hr | Rattus norvegicus |
| T1/2 | 41.0 | hr | Mus musculus |
| T1/2 | 28.0 | hr | Macaca mulatta |
| T1/2 | 27.0 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22037378 | 10.1038/nbt.1990 | Tyrosine-protein kinase ABL1 | 15 |
| 22037378 | 10.1038/nbt.1990 | Epidermal growth factor receptor | 12 |
| 26396681 | 10.1021/ml500526p | Mus musculus | 12 |
| 22037378 | 10.1038/nbt.1990 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| 18183025 | 10.1038/nbt1358 | Epidermal growth factor receptor | 10 |
| 26254279 | 10.18632/oncotarget.4214 | Unchecked | 9 |
| 22037378 | 10.1038/nbt.1990 | Mast/stem cell growth factor receptor Kit | 8 |
| 22037378 | 10.1038/nbt.1990 | Receptor-type tyrosine-protein kinase FLT3 | 7 |
| 18183025 | 10.1038/nbt1358 | Tyrosine-protein kinase ABL1 | 7 |
| 26396681 | 10.1021/ml500526p | Serine/threonine-protein kinase B-raf | 6 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 6 |
| 18183025 | 10.1038/nbt1358 | Mast/stem cell growth factor receptor Kit | 5 |
| 18183025 | 10.1038/nbt1358 | Receptor-type tyrosine-protein kinase FLT3 | 5 |
| 26396681 | 10.1021/ml500526p | Rhesus monkey | 5 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| 26396681 | 10.1021/ml500526p | Rattus norvegicus | 5 |
| 26396681 | 10.1021/ml500526p | Canis familiaris | 5 |
| 26396681 | 10.1021/ml500526p | Plasma | 4 |
| 22037378 | 10.1038/nbt.1990 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| 22037378 | 10.1038/nbt.1990 | Hepatocyte growth factor receptor | 3 |
Data from ChEMBL 36 via Core Engine